ICAM2 and COVID-19: Partly consistent with a previous MR study showing sICAM-2 lowers the risk of severe COVID-19 [21] and in line with another MR study showing ICAM5 lowers the risk of severe COVID-19 [22], we found ICAM-2 and ICAM-5 lower the risk of COVID-19 hospitalization.